Clinical Trials Logo

16P11.2 Deletion Syndrome clinical trials

View clinical trials related to 16P11.2 Deletion Syndrome.

Filter by:
  • None
  • Page 1

NCT ID: NCT04271332 Not yet recruiting - Clinical trials for 16P11.2 Deletion Syndrome

Safety, Tolerability, and Efficacy of Arbaclofen in 16p11.2 Deletion

Start date: March 2020
Phase: Phase 2
Study type: Interventional

This Phase 2 study examines the safety, tolerability, and efficacy of arbaclofen in pediatric subjects with 16p11.2 deletion. Male or female subjects aged 5 to 17 years of age will be randomized to receive either placebo or arbaclofen in a double-blind study design.

NCT ID: NCT01238250 Recruiting - ASXL1 Gene Mutation Clinical Trials

Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight

Start date: October 2010
Phase:
Study type: Observational

Simons Searchlight collects medical, behavioral, learning, and developmental information from people who have gene changes that are linked to autism and other neurodevelopmental disorders. The goal of this study is to improve the clinical care and treatment for these people. Simons Searchlight partners with families to collect data and distribute it to qualified researchers.